One region. Very different markets.
Our market focus spans South and Southeast Asia, alongside major pharmaceutical markets including Japan and South Korea.
Across the region, regulation, reimbursement, healthcare infrastructure and patient access differ significantly. The right route to market depends on the product, patient population and local environment.
- North Asia
- Southeast Asia
- South Asia
Our markets
One region. Very different markets.
North Asia · Japan, South Korea
Highly developed pharmaceutical markets with structured regulatory, reimbursement and specialist healthcare systems
Southeast Asia · Singapore, Malaysia, Thailand, Vietnam, Philippines, Indonesia
Diverse healthcare systems with a mix of named-patient, private-pay, tender and reimbursed routes to market
South Asia · India, Pakistan
Large patient populations with specialist care concentrated in major centres and significant variation in affordability and access
Different markets require different models
Expertise tailor made to your needs
Patient Access
The route to treatment varies by market, from named-patient access and private-pay pathways to registration and reimbursed commercialisation
Healthcare Systems
Specialist treatment may be concentrated in a small number of centres in one country and distributed across a broader hospital network in another
Commercial Approach
Some opportunities justify full registration and launch, while others are better served through focused access programmes or targeted commercial models
Scale and patient need
Vast populations. Urgent need.
~2.5B
People across the markets shown
~4.1M
New cancer cases annually across these markets, approximately one in five worldwide
Sources: UN World Population Prospects 2024; IARC GLOBOCAN 2024
We prioritise markets where patient need, access feasibility and a sustainable commercial opportunity come together.
Let’s talk
Ready to explore the opportunity?
Whether you are considering managed access, registration or a broader regional commercial partnership, we’d welcome a conversation